YOLFTbeta
00

Shandong Sinobioway Biomedicine Co Ltd

002581 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

4.36CNY+0.23 (+5.57%)

Price History

Full chart

Market Stats

Previous Close4.13
Open4.26
Day Range4.20 – 4.54
52-Week Range3.04 – 9.17
Volume5.70M
Market Cap3.36B
P/E (TTM)0.00
Forward P/E15.80
EPS-0.22
Dividend Yield0.00%
Beta0.10
50-Day Avg4.62
200-Day Avg5.92

About

Shandong Sinobioway Biomedicine Co., Ltd. engages in the pharmaceutical manufacturing industry in China. It offers injectable mouse nerve growth factor, human interferon, vaccines, traditional Chinese medicine decoction pieces, and pharmaceutical distribution. The company was founded in 1998 and is based in Shenzhen, China. Shandong Sinobioway Biomedicine Co., Ltd. is the subsidiary of Shenzhen Yilian Technology Co., Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jialin Yue
  • Employees492
  • HeadquartersQimei Building, Shenzhen, China, 255000, China
  • Websitehttps://www.wmm.bio

Leadership

  • Mr. Jialin YueChairman & GM · b. 1968
  • Ms. Ting ZhouFinancial Director, Head of Accounting & Employee Director · b. 1988
  • Ms. Xiaoru ShiSecretary to the Board & Non-Independent Director · b. 1996
  • Mr. Juan Xiong XuDeputy GM & Vice Chairman · b. 1986
  • Mr. Ren YanshenCo-Founder
  • Mr. Chen ZhangliangCo-Founder

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue150.03M177.25M213.80M247.17M246.37M287.53M401.07M624.32M858.29M1.26B1.16B664.59M567.64M276.83M402.71M357.08M429.79M360.41M274.81M
Growth (%)-+18.14%+20.62%+15.61%-0.33%+16.71%+39.49%+55.66%+37.48%+47.37%-8.10%-42.83%-14.59%-51.23%+45.47%-11.33%+20.36%-16.14%-23.75%
Cost of Revenue90.65M111.03M110.18M128.86M128.66M25.07M29.58M72.22M144.62M299.35M255.69M98.55M74.14M54.88M85.83M76.64M93.29M87.67M129.60M
Gross Profit59.38M66.22M103.62M118.31M117.71M262.46M371.48M552.10M713.66M965.53M906.72M566.04M493.50M221.95M316.88M280.44M336.50M272.74M145.21M
Gross Margin39.58%37.36%48.47%47.87%47.78%91.28%92.62%88.43%83.15%76.33%78.00%85.17%86.94%80.18%78.69%78.54%78.29%75.67%52.84%
Operating Expense20.29M23.53M32.23M34.41M39.47M180.86M258.05M345.41M437.57M518.32M440.03M653.66M414.49M417.61M43.80M246.77M629.85M384.21M287.43M
Operating Income39.10M42.70M71.39M83.90M78.24M81.59M113.44M206.69M276.09M447.21M466.69M-87.62M79.01M-195.66M273.08M33.67M-293.35M-111.47M-142.22M
Operating Margin26.06%24.09%33.39%33.94%31.76%28.38%28.28%33.11%32.17%35.36%40.15%-13.18%13.92%-70.68%67.81%9.43%-68.25%-30.93%-51.75%
EBITDA41.35M49.99M81.10M92.63M87.44M93.53M142.39M293.19M340.97M516.94M531.79M48.03M175.62M-116.66M347.46M88.00M-235.81M-104.76M-135.93M
EBITDA Margin27.56%28.20%37.93%37.48%35.49%32.53%35.50%46.96%39.73%40.87%45.75%7.23%30.94%-42.14%86.28%24.65%-54.87%-29.07%-49.46%
Net Income32.63M37.04M58.82M70.26M66.98M73.78M109.38M225.01M250.25M417.70M388.41M-103.75M63.38M-195.93M271.00M-14.68M-332.46M-137.31M-116.28M
Net Income Margin21.75%20.90%27.51%28.42%27.19%25.66%27.27%36.04%29.16%33.02%33.41%-15.61%11.17%-70.78%67.29%-4.11%-77.35%-38.10%-42.31%
R&D---11.24M10.76M9.01M17.60M24.16M29.44M44.00M39.02M45.95M54.66M49.30M38.44M27.29M25.37M25.37M18.87M
R&D as % of Total Revenue---4.55%4.37%3.13%4.39%3.87%3.43%3.48%3.36%6.91%9.63%17.81%9.54%7.64%5.90%7.04%6.87%
Interest Expense12.50K867.31K935.97K949.77K405.78K51.09K8.63M13.40M16.60M5.11M15.19M78.16M40.86M25.43M9.29M10.33M9.05M255.64K1.12M
Interest Expense % of Total Revenue0.01%0.49%0.44%0.38%0.16%0.02%2.15%2.15%1.93%0.40%1.31%11.76%7.20%9.18%2.31%2.89%2.11%0.07%0.41%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets95.54M143.53M164.95M209.68M690.19M729.02M773.80M769.49M2.42B2.69B4.00B4.29B3.41B2.44B2.76B2.86B2.34B2.20B2.17B
Total Liabilities11.60M27.41M35.24M32.34M17.91M24.62M35.49M20.08M271.92M160.16M1.08B1.47B1.03B254.33M286.76M389.46M163.41M173.61M222.00M
Total Equity83.94M116.12M129.71M177.34M672.28M704.41M738.31M749.40M2.08B2.47B2.86B2.75B2.31B2.12B2.39B2.39B2.07B1.92B1.84B
Cash19.27M49.11M41.61M78.29M531.51M480.55M467.70M453.86M873.72M769.10M1.82B1.55B1.12B284.15M187.80M183.80M151.91M506.40M220.25M
Total Debt-20.00M20.00M20.00M--116.56M227.07M113.60M950.00K891.86M1.24B845.35M167.09M177.16M165.35M14.55M2.77M-
Net Debt-19.27M-29.11M-21.61M-58.29M-531.51M-480.55M-351.14M-226.79M-760.12M-768.15M-924.50M-302.73M-275.63M-144.83M-10.64M-18.45M-137.36M-503.64M-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow25.07M46.89M54.06M85.71M74.43M63.04M83.13M80.11M137.73M169.32M271.11M74.46M48.41M18.51M-46.02M-54.49M-36.51M-6.55M-253.73M
Investing Cash Flow-3.69M-31.11M-15.25M-24.45M-27.15M-59.85M-41.84M-17.66M497.55M-124.24M-113.75M-613.30M-66.06M-6.90M-55.83M-38.42M256.65M367.06M-
Financing Cash Flow-12.04M14.07M-46.30M-24.58M405.94M-54.14M-54.14M-76.28M-131.82M-149.74M886.33M268.17M-463.58M-788.45M5.49M47.89M-211.14M-7.97M-
Capital Expenditure5.91M31.11M15.63M29.67M27.15M62.11M42.40M20.59M45.62M44.69M88.13M608.27M36.27M67.70M60.85M31.46M4.32M9.01M179.70M
Free Cash Flow19.16M15.77M38.43M56.04M47.28M922.35K40.73M59.51M92.11M124.63M182.97M-533.81M12.14M-49.19M-106.86M-85.95M-40.82M-15.56M-433.43M
Dividends Paid12.04M17.08M46.30M23.57M43.75M54.14M54.14M70.38M16.88M37.09M50.87K75.53M60.39M55.35M6.71M8.04M10.28M177.36K1.14M
FCF to OCF76.42%33.64%71.09%65.38%63.52%1.46%48.99%74.29%66.88%73.61%67.49%-716.95%25.08%-265.73%232.23%157.75%111.83%237.67%170.82%
Dividend Paid to FCF62.84%108.26%120.49%42.06%92.53%5869.81%132.93%118.26%18.32%29.76%0.03%-14.15%497.46%-112.52%-6.28%-9.36%-25.17%-1.14%-0.26%

Earnings

Report DateOct 20, 2014Dec 31, 2014Apr 17, 2015Aug 19, 2015Oct 25, 2015Dec 31, 2015Apr 24, 2016Aug 11, 2016Oct 21, 2016Feb 26, 2017Apr 27, 2017Aug 30, 2017Oct 27, 2017Dec 31, 2017Apr 30, 2018Aug 21, 2018Oct 22, 2018Dec 31, 2018Apr 24, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 30, 2020Aug 27, 2020Oct 27, 2020Dec 31, 2020Apr 29, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Jan 16, 2024May 22, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 22, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------
EPS Actual0.060.040.100.090.210.160.120.110.180.220.120.150.140.180.12-0.120.01-0.16-0.020.060.040.02-0.10-0.04-0.02-0.140.040.170.32-0.120.000.030.06-0.12-0.03-0.050.13-0.55-0.12-0.000.19-0.23-0.16-0.13-0.01-0.07-0.24-0.06
Surprise------------------------------------------------
TimingPre-market-Pre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-market-Pre-marketAfter-hoursPre-market-Pre-market------------------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap3.36B
Enterprise Value3.23B
Trailing P/E0.00
Forward P/E15.80
Price / Sales11.29
Price / Book1.93
EPS-0.22
Book Value2.69
Revenue (TTM)298.07M
Gross Profit (TTM)82.25M
EBITDA-153.32M
Profit Margin-48.46%
Operating Margin-114.42%
Return on Equity-9.33%
Return on Assets-5.86%
Shares Outstanding659.74M
Shares Float494.62M
Beta0.10
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20161×
0.05Jun 21, 2016
20141×
0.25Jun 6, 2014
20131×
0.19May 22, 2013
20121×
0.19Apr 18, 2012
20111×
0.15Jul 8, 2011

Stock Splits

  • Jul 10, 201520:10
  • May 22, 201313:10